title: High-throughput screening of saliva for early detection of oral cancer: a pilot study.
abstract: The success of tumour therapy depends considerably on early diagnosis. Therefore, we aimed to develop a widely available, cheap, non-invasive, high-throughput method suitable for screening high-risk populations, at least, for early signs of malignant transformation in the oral cavity. First, in order to identify suitable tumour marker candidates, we compared the protein patterns of five selected saliva samples obtained from healthy controls and tumour patients after electrophoretic separation, excised the bands that were consistently up-regulated  in the tumour patients only, and performed matrix-assisted laser-desorption ionisation (MALDI)-time of flight (TOF) tandem mass spectrometry (MS/MS) analysis of the proteins in these bands after in-gel tryptic digestion. From the panel of proteins identified, we chose annexin 1 and peroxiredoxin 2 for further studies based on their presence in the saliva of all five oral cancer patients only. Then, we performed a homology search of protein databases using the primary sequence of each in silico tryptic fragment peptide of these two proteins as bait, and selected a unique peptide for each. Finally, we performed targeted MALDI-TOF MS peptide analysis in a blinded fashion on all samples obtained from 20 healthy controls and 22 tumour patients for the presence of these peptides. We found both peptides present in the saliva samples of all cancer patients only. Even though these tumour markers should be validated in a wider population, our results indicate that targeted MALDI-TOF MS analysis of unique peptides of putative saliva protein tumour biomarkers could be the method of choice for cost-efficient, high-throughput screening for the early detection of oral cancer.
authors.affiliation: Departments of Dentistry, Oral and Maxillofacial Surgery, University of Pecs Medical School, 5 Dischka Gyozo st., 7620 Pecs, Hungary.
authors.forename: I
authors.initials: I
authors.lastname: Szanto
authors.forename: L
authors.initials: L
authors.lastname: Mark
authors.forename: A
authors.initials: A
authors.lastname: Bona
authors.forename: G
authors.initials: G
authors.lastname: Maasz
authors.forename: B
authors.initials: B
authors.lastname: Sandor
authors.forename: G
authors.initials: G
authors.lastname: Gelencser
authors.forename: Z
authors.initials: Z
authors.lastname: Turi
authors.forename: F
authors.initials: F
authors.lastname: Gallyas
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism*; D018277:Carcinoma, Mucoepidermoid / Q000175:diagnosis* / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000378:metabolism; D016022:Case-Control Studies; D055088:Early Detection of Cancer; D005260:Female; D005500:Follow-Up Studies; D057166:High-Throughput Screening Assays; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D009367:Neoplasm Staging; D010865:Pilot Projects; D011379:Prognosis; D040901:Proteomics / Q000379:methods; D012463:Saliva / Q000737:chemistry*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
chemical_list: D014408:Biomarkers, Tumor